CClinicalTrials.gg
Status unknownNCT04149548Updated Feb 6, 2020

Placental Assessment in Diabetic Mothers

An observational study in Diabetes, sponsored by Aljazeera Hospital. Status unknown at 2 sites in Egypt. Open to female participants aged 20 Years to 42 Years. Per ClinicalTrials.gov, last updated 2020-02-06.

Sponsored by Aljazeera Hospital · Observational

The sponsor has not verified this record recently (last verified Feb 2020), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
20 Years to 42 Years
Sex
Female
01

Study summary

Diabetes mellitus is one of the major heath problems

Read the detailed description

Maternal and fetal effects are edpected to be more than in diabetic mothers

02

Conditions studied

  • Diabetes
03

In context

Lead sponsor

Aljazeera Hospital is the lead sponsor of 63 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 42 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Diabetic and non diabetic pregnanrt women attending for ANC

Inclusion criteria

  • in control group A non diabetic pregnant women

Exclusion criteria

Exclusion Criteria:

  • Diabetic pregnant women

And the reverse in group B

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • pregnant diabetic women

    Fetal Ultrasound to diabetic pregnant women

    Diagnostic Test: ultrasound

  • non diabetic pregnant women

    Fetal ultrasound to non diabetic pregnant women

    Diagnostic Test: ultrasound

Interventions

  • Diagnostic testultrasound

    Obstetric ultrasound to pregnant women

06

What researchers measure

Primary outcomes

  1. The number of diabetic fetuses who will have undesirable effects

    Number of fetuses with macrosomia and other diabetes effects

    Time frame: within 6 months

07

Study locations

2 of 2 sites recruiting
  • Algazeerah and Kasralainy hospital
    Giza, Egypt
    • Mahmoud Alalfy, master · Contact · mahmoudalalfy@ymail.com · +201002611058
    • Ahmed Elgazzar, M.D · Contact · +201014005959
    • Mahmoud Alalfy, master · Principal investigator
    Recruiting
  • Algazeerah
    Giza, Egypt
    • Mahmoud Alalfy, master · Contact · mahmoudalalfy@ymail.com · +201002611058
    • Ahmed Elgazzar, M.D · Contact · +201014005959
    • Mahmoud Alalfy, master · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 6, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04149548
Lead sponsor
Aljazeera Hospital
Responsible party
Mahmoud Alalfy (Researcher ,National research centre and Algezeera hospital, Aljazeera Hospital) — Principal investigator
First posted
Nov 4, 2019
Start date
Nov 5, 2019
Primary completion
Nov 6, 2020 (estimated)
Completion
Dec 1, 2020 (estimated)
Last update
Feb 6, 2020

Study contacts

Mahmoud Alalfy, PhD
Contact
mahmoudalalfy@ymail.com
01002611058
Mahmoud Alalfy, PhD
principal investigator · Algezeera

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion